Table 1 Characteristics of patients with six months follow-up before and six months after the index date included in interrupted time series analyses analysis (n = 27657a)
Characteristic | Unauthorized for medical cannabis (N = 17,732) | Authorized for medical cannabis (N = 9925) | p-value |
|---|---|---|---|
Age | |||
< 21 | 143 (0.8%) | 78 (0.8%) | 0.9957 |
21 to 30 | 1855 (10.5%) | 1063 (10.7%) | |
31 to 40 | 3553 (20.0%) | 1993 (20.1%) | |
41 to 50 | 3876 (21.9%) | 2135 (21.5%) | |
to 60 | 4545 (25.6%) | 2562 (25.8%) | |
61 to 70 | 2527 (14.3%) | 1414 (14.3%) | |
71 to 80 | 891 (5.0%) | 491 (5.0%) | |
> 80 | 342 (1.9%) | 189 (1.9%) | |
Sex | |||
Female | 8054 (45.4%) | 4462 (45.0%) | 0.4576 |
Male | 9678 (54.6%) | 5463 (55.0%) | |
Nearest Census based neighborhood income quintile | |||
1 | 3963 (22.4%) | 2212 (22.3%) | 0.9939 |
2 | 3785 (21.4%) | 2103 (21.2%) | |
3 | 3347 (18.9%) | 1893 (19.1%) | |
4 | 3490 (19.7%) | 1959 (19.7%) | |
5 | 3147 (17.8%) | 1758 (17.7%) | |
Rural | 1891 (10.7%) | 797 (8.0%) | < 0.0001 |
Diagnosis codes | |||
Diabetes | 1945 (11.0%) | 1132 (11.4%) | 0.2680 |
Congestive heart failure | 97 (0.6%) | 64 (0.6%) | 0.3051 |
COPD | 2028 (11.4%) | 1187 (12.0%) | 0.1933 |
Asthma | 3438 (19.4%) | 1965 (19.8%) | 0.4096 |
Cancer | 1250 (7.1%) | 726 (7.3%) | 0.4110 |
Musculoskeletal issues | 7791 (43.9%) | 4377 (44.1%) | 0.7931 |
Neurologic disorders | 2564 (14.5%) | 1515 (15.3%) | 0.0702 |
Pain | 401 (2.3%) | 280 (2.8%) | 0.0040 |
Behavioural issues | 3313 (18.7%) | 1929 (19.4%) | 0.1259 |
Fatigue | 188 (1.1%) | 139 (1.4%) | 0.0120 |
Metabolic disease | 2132 (12.0%) | 1286 (13%) | 0.0236 |
Anxiety at baseline | 4313 (24.3%) | 4867 (49.0%) | < 0.0001 |